Incidence of drug-related adverse events related to the use of high-alert drugs: A systematic review of randomized controlled trials

被引:0
|
作者
Menezes, Michelle Santos [1 ]
Doria, Grace Anne Azevedo [1 ]
Valenca-Feitosa, Fernanda [2 ]
Pereira, Sylmara Nayara [2 ]
Silvestre, Carina Carvalho [3 ]
de Oliveira, Alfredo Dias [2 ]
Lobo, Iza Maria Fraga [4 ]
Quintans-Junior, Lucindo Jose [5 ,6 ]
机构
[1] Univ Fed Sergipe, Cidade Univ Prof Jose Aloisio Campos, BR-49100000 Jardim Rosa Elze, Sao Cristovao, Brazil
[2] Univ Fed Sergipe, Dept Pharm, Lab Teaching & Res Social Pharm LEPFS, Cidade Univ Prof Jose Aloisio Campos, BR-49100000 Jardim Rosa Elze, Sao Cristovao, Brazil
[3] Univ Fed Juiz de Fora, Governador Valadares Campus,Univ Campus,Rua Jose L, BR-36036900 Juiz de Fora, MG, Brazil
[4] Univ Fed Sergipe, Univ Hosp, R Claudio Batista Palestine, BR-49060676 Aracaju, SE, Brazil
[5] Fed Univ Sergipe DFS UFS, Physiol Dept, Jardim Rosa Elze, Sao Cristovao, Brazil
[6] Univ Fed Sergipe, Lab Neurosci & Pharmacol Tests LANEF, Jardim Rosa Elze, Rua Marechal Rondon S-N, BR-49100000 Jardim Rosa Elze, Sao Cristovao, Brazil
关键词
Patient safety; Medication errors; Hospital; High-alert medication or dangerous drugs; SEVERE APLASTIC-ANEMIA; ANTITHYMOCYTE GLOBULIN; RAPID TRANQUILIZATION; ATRIAL-FIBRILLATION; SKIN NECROSIS; CYCLOSPORINE; HALOPERIDOL; MORTALITY;
D O I
10.1016/j.rcsop.2024.100435
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: High-alert medication (HAM) is more predictable to cause significant harm to the patient, even when used as intended. The damage related to the HAM lead not only suffering to the patient, but also raise the additional costs associated with care. Objective: Evaluate the incidence of drug-related adverse events related to the use of high-alert medications. Methods: It was conducted an active search for information through COCHRANE databases, LILACS, SciELO, SCOPUS, PubMed/MEDLINE and WEB OF SCIENCE. The search strategy included the following terms: "Patient safety", "Medication errors" and "Hospital" and "High Alert Medications" or "Dangerous Drugs" in different combinations. Then two reviewers independently conducted a preliminary evaluation of relevant titles, abstracts and finally full-text. Studies quality was evaluated according to PRISMA declaration. Results: The systematic review evaluated seven articles, which showed that only 11 HAM identified in the literature could have serious events. The most frequently cited were warfarin (22.2%) which progressed from deep vein thrombosis to gangrene, suggesting lower initial doses, followed by cyclophosphamide (22.2%) and cyclosporine (22.2%) which presented invasive fungal infection and death. In addition to these, morphine was compared with its active metabolite (M6G), with M6G causing fewer serious clinical events related to nausea and vomiting, reducing the need for concomitant use of antiemetics. Conclusions: The most reported drug classes in the articles included that were related to incidence of drug-related adverse events in use of high-alert medications: morphine, M6G-glucuronide, haloperidol, promethazine, ivabradine, digoxin, warfarin, ximelagatran, cyclophosphamide, cyclosporine, and ATG. The formulate protocols for the use of these medications, with importance placed on evaluating, among the classes, the medication that causes the least harm.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] A systematic review of adult admissions to ICUs related to adverse drug events
    Pierre-Alain Jolivot
    Patrick Hindlet
    Claire Pichereau
    Christine Fernandez
    Eric Maury
    Bertrand Guidet
    Gilles Hejblum
    Critical Care, 18
  • [23] Cognitive Enhancers and Risk of Fall-Related Adverse Events - Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Kim, D.
    Brown, R.
    Berry, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 99 - 99
  • [24] Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
    Underwood, Jonathan
    Marks, Michael
    Collins, Steve
    Logan, Sarah
    Pollara, Gabriele
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (03) : 787 - 790
  • [25] The incidence of stoma related morbidity - a systematic review of randomised controlled trials
    Malik, T. A. M.
    Lee, M. J.
    Harikrishnan, A. B.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2018, 100 (07) : 501 - 508
  • [26] Sleep-related adverse events of smoking cessation drugs: A network meta-analysis of randomized controlled trials
    Song, Yubin
    Park, Yoon-A
    Lee, Da Hoon
    Yee, Jeong
    Gwak, Hye Sun
    PSYCHIATRY RESEARCH, 2024, 335
  • [27] Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
    Macki M.
    Dabaja A.A.
    Basic and Clinical Andrology, 26 (1)
  • [28] Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials
    Lee, Ji Young
    Jun, Seung Ah
    Hong, Sung Shin
    Ahn, Yo Chan
    Lee, Dong Soo
    Son, Chang Gue
    PHYTOTHERAPY RESEARCH, 2016, 30 (09) : 1412 - 1419
  • [29] The incidence and risks of adverse events in randomized controlled trials (RCTs) of cancer drugs downplaying the harms.
    Gyawali, Bishal
    Honda, Kazunori
    Shimokata, Tomoya
    Ando, Yuichi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] THE ROLE OF DRUG-RELATED ADVERSE PATIENT EVENTS IN ACUTE HOSPITAL ADMISSIONS
    MITENKO, PA
    NAUJOKS, SR
    SITAR, DS
    AOKI, FY
    MONTGOMERY, PR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 210 - 210